mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
0.0003 |
mRNA |
Compound 23 citrate |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0004 |
mRNA |
cyanoquinoline 11 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
0.002 |
mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
-0.19 |
0.002 |
mRNA |
selumetinib:JQ-1 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.002 |
mRNA |
fluvastatin |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.003 |
mRNA |
Gemcitabine |
gCSI |
pan-cancer |
AAC |
-0.19 |
0.004 |
mRNA |
KHS101 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.004 |
mRNA |
simvastatin |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.005 |
mRNA |
SRT-1720 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.005 |